RLFTF MindMaze Therapeutics Holding SA — earnings, filings & institutional moves

Price chart

Daily historical data with per-account defaults

Latest close

$0.31

Period return

-1.16 (-78.91%)

Volume

200

2026-08-07O $0.31 H $0.31 L $0.31 C $0.31MA5 $0.29MA20 $0.24MA60 $0.34MA120 $0.48

6M · 123 barsYahoo Finance · USD2026-02-11 → 2026-08-07

Recent event timeline

Filings, earnings, research, and institutional changes — newest first

View all →

No events to show.

Recent earnings

Consensus vs. actual, and revenue trend

Earnings tab →

Research actions

Rating & price-target changes

Research tab →

AI Brief (Premium)

Automated summary from public sources · not investment advice

Brief tab →

No AI brief generated yet. You can create one from the Brief tab.

Top institutions (13F)

Ranked by position value

Institutions tab →

Company info

MindMaze Therapeutics Holding SA operates as a commercial-stage biopharmaceutical and neurotechnology company in Asia, the United States, Switzerland, rest of Europe, and internationally. The company offers MindPod system, a supervised in-clinic neurorehabilitation system designed to initiate and intensify the recovery journey; MindMotion GO, which extends protocolized neurotherapeutics into outpatient and home settings; MindMotion Companion, an application that manages prescription, monitoring and documentation across MindMaze Therapeutics' neurotherapeutics ecosystem; and the patient app, a patient-facing mobile application, that supports clinic-to-home continuity by making prescribed therapy easy to follow outside the clinic. It also provides Izar hand therapy device which supports fine motor rehabilitation; Physilog sensor, a wearable inertial sensing device designed to quantify human movement; toaprun, a training for Parkinson's therapy-reimagined through play. The company was founded in 2012 and is headquartered in Geneva, Switzerland.

Sector
Industry: —
HQ: Geneva, Switzerland
Fiscal year end: —
Employees: 10
IPO date: —

MindMaze Therapeutics Holding SA

Price chart

Recent event timeline

Recent earnings

Research actions

Top news

Key stats